Patnaik Lab. Akash patnaik, md, phd, mmsc, is a medical oncologist specializing in the care of patients with genitourinary cancers, including prostate, bladder, kidney and. Patnaik and his research team focus on early phase drug development of kinase inhibitors and immunotherapy, with the goal of. © 2019 the university of chicago all rights reserved. Laboratory manager and staff scientist. The patnaik lab is a translational research program that aims to find cures for prostate cancer by enhancing immunotherapy. Bladder cancer, developmental therapeutics, kidney cancer,. He directs a research lab and a center for epigenomics development, and leads clinical trials and drug.
from voices.uchicago.edu
© 2019 the university of chicago all rights reserved. The patnaik lab is a translational research program that aims to find cures for prostate cancer by enhancing immunotherapy. Laboratory manager and staff scientist. Akash patnaik, md, phd, mmsc, is a medical oncologist specializing in the care of patients with genitourinary cancers, including prostate, bladder, kidney and. Patnaik and his research team focus on early phase drug development of kinase inhibitors and immunotherapy, with the goal of. Bladder cancer, developmental therapeutics, kidney cancer,. He directs a research lab and a center for epigenomics development, and leads clinical trials and drug.
Translational Research Team Patnaik Lab
Patnaik Lab Patnaik and his research team focus on early phase drug development of kinase inhibitors and immunotherapy, with the goal of. Bladder cancer, developmental therapeutics, kidney cancer,. The patnaik lab is a translational research program that aims to find cures for prostate cancer by enhancing immunotherapy. © 2019 the university of chicago all rights reserved. Laboratory manager and staff scientist. Patnaik and his research team focus on early phase drug development of kinase inhibitors and immunotherapy, with the goal of. Akash patnaik, md, phd, mmsc, is a medical oncologist specializing in the care of patients with genitourinary cancers, including prostate, bladder, kidney and. He directs a research lab and a center for epigenomics development, and leads clinical trials and drug.